Literature DB >> 11577809

Health literacy and shared decision making for prostate cancer patients with low socioeconomic status.

S P Kim1, S J Knight, C Tomori, K M Colella, R A Schoor, L Shih, T M Kuzel, R B Nadler, C L Bennett.   

Abstract

Quality of life (QOL) considerations are important in the treatment decision making process for prostate cancer patients. Although patient involvement in the treatment decision process has been encouraged, low health literacy can limit patient understanding of the complex information about treatments and their probable QOL outcomes and is a barrier to patient participation in the decision-making process. The objectives of the study were to evaluate (i) knowledge, level of satisfaction, and treatment preferences and intentions of men newly diagnosed with prostate cancer after participation in a CD-ROM shared decision making program; and (ii) the relationship between prostate cancer knowledge and health literacy. Thirty newly diagnosed prostate cancer patients from two Veteran's Administration (VA) hospitals in Chicago completed a demographic questionnaire and participated in an interactive CD-ROM shared decision making program. Subsequently, knowledge of prostate cancer, satisfaction with the information in the computer CD-ROM program, treatment preferences, and likelihood of following treatment preferences were assessed using interviewer-administered questionnaires. Health literacy was assessed using the Rapid Estimate of Adult Literacy in Medicine (REALM). The Pearson correlation test was used to assess the relationship between health literacy and prostate cancer knowledge. The chi2 test and the Fischer exact test were used to evaluate relationships between patient demographics and other variables. More than three-quarters of the patients rated the information in the CD-ROM as "very satisfactory" (highest possible rating). Two-thirds of the patients (21 of 30) selected a treatment after participation in the CD-ROM program and 90.5% of these patients stated that they were very or somewhat likely to adhere to their selection. However, prostate cancer knowledge was variable, with one-third of the patients scoring 69.9% or lower. Participants' health literacy was equivalent to a 7th-8th grade reading level (mean = 57.1+/-10.9), and more than one-third of participants (36.7%) had lower than 9th grade literacy levels. Participants' prostate cancer knowledge was correlated with health literacy (Pearson correlation rhor = 0.65, rhop = 0.0001). Patients were satisfied with the interactive shared decision making CD-ROM program, and two-thirds of patients were able to select a preferred treatment based on the information presented in the program that they intended to follow. However, prostate cancer knowledge scores varied among participants after participation in the CD-ROM program, raising doubts that patients were adequately informed to make appropriate choices regarding their treatment. Lower prostate cancer knowledge scores corresponded to lower literacy scores, indicating that low literacy may have hindered patient understanding of the shared decision making program. The development of shared decision making tools should include collaborative efforts with the target population to improve the success of shared decision making programs among patients with low health literacy.

Entities:  

Mesh:

Year:  2001        PMID: 11577809     DOI: 10.1081/cnv-100106143

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  74 in total

1.  Barbershop communications on prostate cancer screening using barber health advisers.

Authors:  John S Luque; Brian M Rivers; Clement K Gwede; Maisha Kambon; B Lee Green; Cathy D Meade
Journal:  Am J Mens Health       Date:  2010-04-21

2.  Low-literacy interventions to promote discussion of prostate cancer: a randomized controlled trial.

Authors:  Sunil Kripalani; Jyoti Sharma; Elizabeth Justice; Jeb Justice; Cynthia Spiker; Larry E Laufman; Megan Price; Armin D Weinberg; Terry A Jacobson
Journal:  Am J Prev Med       Date:  2007-08       Impact factor: 5.043

3.  The prevalence of limited health literacy.

Authors:  Michael K Paasche-Orlow; Ruth M Parker; Julie A Gazmararian; Lynn T Nielsen-Bohlman; Rima R Rudd
Journal:  J Gen Intern Med       Date:  2005-02       Impact factor: 5.128

Review 4.  Managing the low-socioeconomic-status prostate cancer patient.

Authors:  Walter Rayford
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

5.  Integrating literacy, culture, and language to improve health care quality for diverse populations.

Authors:  Dennis P Andrulis; Cindy Brach
Journal:  Am J Health Behav       Date:  2007 Sep-Oct

6.  Provider perceptions of limited health literacy in community health centers.

Authors:  Jennifer A Schlichting; Michael T Quinn; Loretta J Heuer; Cynthia T Schaefer; Melinda L Drum; Marshall H Chin
Journal:  Patient Educ Couns       Date:  2007-09-21

7.  Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: baseline results from a shared decision-making trial.

Authors:  Alan L Kaplan; Catherine M Crespi; Josemanuel D Saucedo; Sarah E Connor; Mark S Litwin; Christopher S Saigal
Journal:  Cancer       Date:  2014-05-09       Impact factor: 6.860

8.  Using animation as an information tool to advance health research literacy among minority participants.

Authors:  Sheba George; Erin Moran; Nelida Duran; Robert A Jenders
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

9.  Improving physician-patient communication about cancer pain with a tailored education-coaching intervention.

Authors:  Richard L Street; Christina Slee; Donna K Kalauokalani; Dionne Evans Dean; Daniel J Tancredi; Richard L Kravitz
Journal:  Patient Educ Couns       Date:  2009-12-04

10.  African American men's understanding and perceptions about prostate cancer: why multiple dimensions of health literacy are important in cancer communication.

Authors:  Daniela B Friedman; Sara J Corwin; Gregory M Dominick; India D Rose
Journal:  J Community Health       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.